Lilly to Participate in SVB Securities Global Biopharma Conference

Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) will participate in the SVB Securities Global Biopharma Conference on February 16, 2023. Ilya Yuffa, Executive Vice President and President of Lilly International, will take part in a virtual fireside chat at 12 p.m. Eastern time. A live audio webcast will be available on Lilly's Investor website, with a replay accessible for approximately 90 days thereafter. Lilly has been a leader in creating innovative treatments, helping over 47 million people globally. Their research focuses on serious health challenges, including diabetes, obesity, Alzheimer's, and certain cancers.

News Market Reaction – LLY

+0.60%

+0.60% Session move

In the trading session that priced this news, LLY gained 0.60%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

INDIANAPOLIS, Feb. 7, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the SVB Securities Global Biopharma Conference on Thursday, Feb. 16, 2023. Ilya Yuffa, executive vice president and president, Lilly International, will participate in a virtual fireside chat at 12 p.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram and LinkedIn. F-LLY

Refer to:	Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
	Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors)

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-svb-securities-global-biopharma-conference-301739752.html

SOURCE Eli Lilly and Company

FAQ

When will Eli Lilly participate in the SVB Securities Global Biopharma Conference?

Eli Lilly will participate in the SVB Securities Global Biopharma Conference on February 16, 2023.

Who will represent Eli Lilly at the conference?

Ilya Yuffa, Executive Vice President and President of Lilly International, will represent Eli Lilly.

What time is Eli Lilly's presentation at the biopharma conference?

Eli Lilly's presentation will be at 12 p.m. Eastern time.

How can I access the webcast for Eli Lilly's presentation?

The live audio webcast can be accessed on Lilly's Investor website under the 'Webcasts & Presentations' section.

Will there be a replay of Eli Lilly's conference presentation?

Yes, a replay of the presentation will be available for approximately 90 days on Lilly's Investor website.

What is Eli Lilly's mission regarding patient care?

Eli Lilly aims to create medicines that improve lives, focusing on significant health challenges worldwide.